Search
semaxinib (SU5416)
Dosage:
- BID
Mechanism of action:
- targets VEGFR 1-3, also PDGFR, c-kit, Flt-3
Clinical trials: phase 3 trials, disappointing results
General
small inhibitory antineoplastic agent (ib drug)
Database Correlations
PUBCHEM correlations